Faricimab
Product Specifications
CAS Number
1607793-29-2
Target
RAAS, VEGFR
Related Pathways
Endocrinology/Hormones, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
>95%
Bioactivity
Faricimab, a bispecific antibody targeting Angiopoietin-2 (Ang-2) and VEGF-A. Faricimab prevents retinal ischemia/reperfusion (I/R) injury and vascular leakage, cell death, and inflammation in sCNV mouse models, showing superior visual acuity improvement over ranibizumab for retinal diseases including w-AMD, DME, and RVO.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15136435 1 Vial
Lentiviral mouse Med25 shRNA (UAS) - Lentiviral mouse Med25 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
MBS1022071-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB)
Sign In for Pricing
View Details MBS1022071-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB)
Sign In for Pricing
View Details MBS1022071-03 0.02 mg (Yeast)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB)
Sign In for Pricing
View Details MBS1022071-04 0.1 mg (Yeast)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB)
Sign In for Pricing
View Details MBS1022071-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB)
Sign In for Pricing
View Details